Since the outbreak of the novel coronavirus, Guangzhou Yuanqi Health Technology Co., Ltd. has quickly organized the company's research and development forces, and launched scientific research on the novel coronavirus 2019-NCoV. Through the unremitting efforts of the company's research and development team, we have overcome many difficulties in the research and development process, successfully completed the development of the novel coronavirus 2019-NCoV nucleic acid detection kit (fluorescent PCR method), and obtained the EU CE certification, making a contribution to the global fight against the spread of the epidemic.

Detection of all diseases are diagnosed first, get the CE certification, means that guangzhou origin healthy technology co., LTD., a new type of coronavirus 2019 - nCoV nucleic acid detection kit (fluorescence PCR method) in accordance with the European Union health, safety, environmental protection and consumer protection the requirements stipulated in the relevant laws, and be able to in the circulation of more than 10 countries and regions in the world "the sea".

"This is an important step for us to reach the international market and a major milestone in our response to public health emergencies, following the EU CE certification for our self-developed Micgene 244 IVD real-time PCR instrument and the EU CE certification for our COVID-19 test kit." Guangzhou Yuanqi Health Technology Co., LTD. General manager Li Genping said. In the next step, we will actively promote the application of the kit in the EU market, so as to provide a powerful testing weapon for the prevention and control of the COVID-19 epidemic in EU countries.